NCT01547130
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +9 more
- Locations
-
- Vikalp Inc. Middle Village, New York, United States
Clinical trial condition
Colorectal Neoplasms
Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.
4,239 public trials
881 recruiting studies
Colorectal Neoplasms trial results
Completed
ColoAssist vs. MEI
NCT01895504
- Conditions
- Adenoma, Colonic Diseases, Colorectal Cancer, +13 more
- Locations
-
- SSHF Arendal Arendal, Norway
- SSHF Kristiansand Kristiansand, Norway
NCT01495663
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +50 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Georgetown University Hospital Washington D.C., District of Columbia, United States
- University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
NCT00441337
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +52 more
- Locations
-
- Johns Hopkins Unv., School of Medicine Baltimore, Maryland, United States
- Henry Ford Health System Detroit, Michigan, United States
- Washington University School of Medicine - Barnes Jewish Hospital St Louis, Missouri, United States
- Carolina BioOncology Institute, PLLC Huntersville, North Carolina, United States
NCT01135498
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
- Locations
-
- Palma de Mallorca, Balearic Islands, Spain
- Sabadell, Barcelona, Barcelona, Spain
- Terrassa, Barcelona, Spain
- Burgos, Spain
NCT01998009
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
- Locations
-
- Indiana University Indianapolis, Indiana, United States
- University of Minnesota Minneapolis, Minnesota, United States
NCT00904839
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
- Locations
-
- 1199.51.32002 Boehringer Ingelheim Investigational Site Bonheiden, Belgium
- 1199.51.32005 Boehringer Ingelheim Investigational Site Brussels, Belgium
- 1199.51.32006 Boehringer Ingelheim Investigational Site Brussels, Belgium
- 1199.51.32001 Boehringer Ingelheim Investigational Site Leuven, Belgium
Completed
FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor
NCT00660582
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
- Locations
-
- Department of Oncology, Aalborg University Hospital Aalborg, Denmark
- Department of Oncology, Herlev University Hospital Herlev, Denmark
- Department of Oncology, Odense University Hospital Odense, Denmark
- Department of Oncology, Haukeland University Hospital Bergen, Norway
NCT01483001
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +20 more
- Locations
-
- Department of Medical Oncology Livorno, Italy
NCT00484939
- Conditions
- Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
- Locations
-
- Innsbruck, Austria
- Linz, Austria
- Salzburg, Austria
- Vienna, Austria